The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia

Madeline Niederkorn(International Society for Experimental Hematology), Daniel T. Starczynowski(Cincinnati Children's Hospital Medical Center)

Leukemia

August 31, 2021

10.1038/s41375-021-01394-z

Cited by 60

Related Papers

Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome

|Leukemia|2025|4

FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome

|Journal of Clinical Investigation|2026|0